| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |